Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» biosimilars
biosimilars
Amgen, Allergan step up to challenge Roche's Avastin with FDA biosim filing
Fierce Pharma
Wed, 11/16/16 - 09:57 am
Amgen
Allergan
Roche
Avastin
biosimilars
FDA
ABP 215
AbbVie: Take That Coherus!
Barron's
Tue, 11/8/16 - 09:58 am
AbbVie
Coherus Biosciences
Humira
biosimilars
Doctors willing to prescribe biosimilars, survey shows
BioPharma Dive
Thu, 11/3/16 - 09:38 am
biosimilars
physicians
Could This Look-A-Like Drug Be Merck's Next Big Seller?
Motley Fool
Sat, 10/29/16 - 01:21 pm
MK-1293
Merck
diabetes
insulin
Lantus
biosimilars
FDA approval could be delayed for Sanofi Genzyme’s next blockbuster
Bizjournals.com
Fri, 10/28/16 - 10:19 am
FDA
Sanofi
Sanofi Genzyme
drug manufacturing
biosimilars
Humira
Sarilumab
Could Pfizer's at-risk Inflectra launch set a biosimilars precedent for Amgen, Novartis?
Fierce Pharma
Mon, 10/24/16 - 09:50 am
Pfizer
drug launches
biosimilars
Inflectra
Amgen
Novartis
AbbVie Is Under Duress With Fierce Competition
Seeking Alpha
Thu, 10/20/16 - 09:20 am
AbbVie
Humira
biosimilars
Amgen
Baxalta
Shire
J&J optimistic in spite of biosimilar threat
BioPharma Dive
Wed, 10/19/16 - 10:39 am
JNJ
biosimilars
Remicade
Pfizer
rheumatoid arthritis
Pfizer set to start shipping Remicade biosimilar next month
Yahoo/Reuters
Tue, 10/18/16 - 12:03 am
Pfizer
Remicade
biosimilars
Inflectra
JNJ
rheumatoid arthritis
Merck Launches Biosimilars Clarified, a New Online Educational Resource about Biosimilar Medicines for Patients and the Healthcare Community
Yahoo
Fri, 10/14/16 - 11:44 am
Merck
biosimilars
patients
patient education
Teva ponies up $160M-plus for marketing rights to Celltrion's Rituxan, Herceptin biosims
Fierce Pharma
Fri, 10/7/16 - 09:11 am
Teva Pharmaceutical
Celltrion
Rituxan
Herceptin
biosimilars
Big Pharma vs Big Pharma in court battles over biosimilar drugs
Yahoo/Reuters
Mon, 10/3/16 - 09:58 am
Big Pharma
patents
biosimilars
Novartis
Amgen
Biogen
Sanofi
Merck
Eli Lilly
Pfizer
JNJ
FDA Approval of Amjevita Need Not Worry AbbVie Shareholders
Yahoo/GuruFocus
Thu, 09/29/16 - 08:14 am
FDA
AbbVie
Amgen
biosimilars
Humira
Amjevita
Shire punts late-stage biosimilars of Humira and Enbrel back to Momenta, Coherus
Endpoints
Wed, 09/28/16 - 10:18 am
Shire
biosimilars
Humira
Enbrel
Momenta
How Much Will Consumers Save on New Humira Biosimilar?
24/7 Wall St
Mon, 09/26/16 - 09:48 am
Humira
biosimilars
Amjevita
AbbVie
Amgen
FDA approves Amgen's copy of AbbVie arthritis drug Humira
Yahoo/Reuters
Fri, 09/23/16 - 10:24 pm
FDA
Amgen
Humira
rheumatoid arthritis
AbbVie
biosimilars
Amgen Products Threatened by Court Losses
Investopedia
Mon, 09/19/16 - 03:45 pm
Amgen
Apobiologix
Neupogen
Grastofil
Neulasta
Lapelga
biosimilars
patents
Amgen's Biosimilar Approval And Astra's Anti-PD-L1 Data
Seeking Alpha
Sun, 09/18/16 - 09:54 am
Amgen
biosimilars
AstraZeneca
anti-PD-L1
ABP 501
Humira
durvalumab
FDA to Hold One Advisory Committee for Each Initial Biosimilar
RAPS.org
Wed, 09/14/16 - 09:42 am
FDA
biosimilars
advisory panels
With Biogen launch, the U.K. has two anti-TNF biosims. In the U.S.? Not soon, analyst says
Fierce Pharma
Thu, 09/8/16 - 06:37 pm
Biogen
UK
anti-TNF
biosimilars
Flixabi
Remicade
Enbrel
Benepali
Pages
« first
‹ previous
…
22
23
24
25
26
27
28
29
30
…
next ›
last »